COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline. Issue 4 (26th April 2022)

• Record Type: Journal Article
• Authors: Seyedi, Seyed Javad; Sadeghi, Hossein; Kianifar, Hamid‐Reza; Hamedi, Abdolkarim; Saeidinia, Amin
• Is Part Of: Clinical case reports. Volume 10:Issue 4(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-04-26
• Subjects: children -- COVID‐19 -- cystic fibrosis; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.5782
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Pulmonary infections represent the major causes of morbidity and mortality in cystic fibrosis (CF). Here, we report a 3‐month‐old infant with pancreatic insufficient CF was hospitalized with positive RT‐PCR test for COVID‐19. He was treated successfully. Hypertonic saline can be hypothesized as a treatment regimen against COVID‐19 infection after further investigations. Abstract : Children with CF have underlying lung disease that is associated with pulmonary exacerbation by viral infections. We also proposed that hypertonic saline might be considered as a therapeutic option for COVID‐19.